Polarean Imaging (GB:POLX) has released an update.
Polarean Imaging PLC, a pioneer in advanced MRI technology for lung function, will announce its half-year results on September 4, 2024, and will host a live presentation for shareholders on the Investor Meet Company platform. The presentation will address key questions and a recording will be made available post-event. Polarean, known for its revolutionary FDA-approved XENOVIEW™ MRI contrast agent, continues to address chronic respiratory diseases, impacting over 500 million patients globally.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
